Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stable crystal form of avibactam sodium and preparation method thereof

A crystal form and stable technology, applied in the field of drug-stabilized crystal form of Avibatana and its preparation, can solve problems such as being unsuitable for industrial production, and achieve the effect of high yield

Pending Publication Date: 2020-09-22
HAINAN HAILING CHEMIPHARMA CORP
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] This method uses a lot of column separation and is not suitable for industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stable crystal form of avibactam sodium and preparation method thereof
  • Stable crystal form of avibactam sodium and preparation method thereof
  • Stable crystal form of avibactam sodium and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1 Preparation of (1R,2S,5R)-7-oxo-6-sulfonyloxy-1,6-diazabicyclo[3,2,1﹞octane-2-carboxamide sodium salt

[0022] Add 2.25L absolute ethanol and 300g (1R,2S,5R)-7-oxo-6-sulfonyloxy-1,6-diazabicyclo﹝3,2,1﹞octane to a 5L reaction flask -Tributylbenzyl ammonium salt of 2-carboxamide, stir to dissolve, filter, heat the filtrate to 35-40°C, add 1.68L absolute ethanol, 120ml purified water, 184.4g ethylhexyl dropwise at 35-40°C Sodium acid solution. After the dropwise addition, a solid was precipitated, then the temperature was lowered to 15-25° C., stirring and crystallization was continued for 4 h, and a white solid was obtained by filtration and drying, with a yield of 70-80%.

[0023] Record the X-ray diffraction pattern in the attached figure 1 middle.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an effective stable crystal form of avibactam sodium ((1R, 2S, 5R)-7-oxo-6-sulfonyloxy-1, 6-diazabicyclo(3, 2, 1)octane-2-formamide sodium salt) and a preparation method. The crystal form compound is a drug stable crystal form and has a wide application prospect.

Description

technical field [0001] The invention relates to a drug stable crystal form of avibactaner and a preparation method thereof. Background technique [0002] Ceftazidime Avibactam for injection was the first Actavis listed on the FDA in February 2015, under the trade name Avycaz. Compound patents CN1289500C, CN103649051B, and CN105294690B disclose a method for preparing Avibatana. The basic route of the method is as follows: [0003] [0004] This method has used a lot of column separation, is not suitable for industrialized production. Contents of the invention [0005] The purpose of the present invention is to provide a stable crystal form of avibactam sodium medicine and a preparation method thereof, which is widely used, and the main contents of the invention are as follows:. [0006] A drug stable crystal form of Avibactaner, characterized in that its X-ray diffraction pattern has 5 characteristic peaks at 2θ13.0±0.5, 16.5±0.5, 17.3±0.5, 17.5±0.5, and 22.4±0.5, And...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D471/08
CPCC07D471/08C07B2200/13
Inventor 蔡亲路国荣韩勇王远景
Owner HAINAN HAILING CHEMIPHARMA CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products